Publications 2022

Müller EG, Edwin TH, Strand BH, Stokke C, Revheim ME, Knapskog AB (2022)
Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
J Alzheimers Dis, 85 (1), 197-205
DOI 10.3233/JAD-215046, PubMed 34776444

Müller EG, Stokke C, Stokmo HL, Edwin TH, Knapskog AB, Revheim ME (2022)
Evaluation of semi-quantitative measures of ¹⁸F-flutemetamol PET for the clinical diagnosis of Alzheimer's disease
Quant Imaging Med Surg, 12 (1), 493-509
DOI 10.21037/qims-21-188, PubMed 34993096

Persson K, Edwin TH, Knapskog AB, Tangen GG, Selbæk G, Engedal K (2022)
Hippocampal Atrophy Subtypes of Alzheimer's Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications
Dement Geriatr Cogn Disord, 51 (1), 80-89
DOI 10.1159/000522382, PubMed 35344967

Publications 2021

Aksnes M, Tiiman A, Edwin TH, Terenius L, Bogdanović N, Vukojević V, Knapskog AB (2021)
Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer's Disease
Front Aging Neurosci, 12, 608628
DOI 10.3389/fnagi.2020.608628, PubMed 33488383

Aksnes M, Aass HCD, Tiiman A, Edwin TH, Terenius L, Bogdanović N, Vukojević V, Knapskog AB (2021)
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
Transl Neurodegener, 10 (1), 18
DOI 10.1186/s40035-021-00244-3, PubMed 34099032

Edwin TH, Strand BH, Persson K, Engedal K, Selbaek G, Knapskog AB (2021)
Neuropsychiatric symptoms and comorbidity: Associations with dementia progression rate in a memory clinic cohort
Int J Geriatr Psychiatry, 36 (6), 960-969
DOI 10.1002/gps.5500, PubMed 33462872

Publications 2020

Aksnes M, Müller EG, Tiiman A, Edwin TH, Terenius L, Revheim ME, Vukojević V, Bogdanović N, Knapskog AB (2020)
Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort
J Alzheimers Dis, 77 (2), 831-842
DOI 10.3233/JAD-200237, PubMed 32741818

Edwin TH, Henjum K, Nilsson LNG, Watne LO, Persson K, Eldholm RS, Saltvedt I, Halaas NB, Selbæk G, Engedal K, Strand BH, Knapskog AB (2020)
A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's disease
Alzheimers Dement (Amst), 12 (1), e12128
DOI 10.1002/dad2.12128, PubMed 33313376

Edwin TH, Strand BH, Persson K, Engedal K, Selbæk G, Knapskog AB (2020)
Trajectories and risk factors of dementia progression: a memory clinic cohort followed up to 3 years from diagnosis
Int Psychogeriatr, 33 (8), 779-789
DOI 10.1017/S1041610220003270, PubMed 33213607

Mjørud M, Selbæk G, Bjertness E, Edwin TH, Engedal K, Knapskog AB, Strand BH (2020)
Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis
PLoS One, 15 (12), e0243513
DOI 10.1371/journal.pone.0243513, PubMed 33275638

Publications 2019

Müller EG, Edwin TH, Stokke C, Navelsaker SS, Babovic A, Bogdanovic N, Knapskog AB, Revheim ME (2019)
Amyloid-β PET-Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic
PLoS One, 14 (8), e0221365
DOI 10.1371/journal.pone.0221365, PubMed 31430334

Publications 2018

Strand BH, Knapskog AB, Persson K, Edwin TH, Amland R, Mjørud M, Bjertness E, Engedal K, Selbæk G (2018)
Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway
PLoS One, 13 (9), e0204436
DOI 10.1371/journal.pone.0204436, PubMed 30240425